Celebration: 04/03/2013 - 06/03/2013
TAT 2013 (International Congress on Targeted Anticancer Therapies)
París, Francia
TAT 2013 in Paris, March 4-6 , 2013, will be the next meeting in the unique series "International Congress on Targeted Anticancer Therapies" (TAT), which is devoted to the most promising new molecularly-targeted cancer therapeutics.
TAT meetings are leading oncology phase 1 meetings in Europe and a must-attend for clinical investigators, research scientists and drug development professionals in pharma, biotech and CROs:

Focus on promising new agents and molecular targets that are - or soon will be - in phase 1 clinical study
Clinical and translational research discussed extensively
Educational introductions of target biology help "newcomers" understand the science behind new targets
Open, academic atmosphere and highly interactive setting
Completely plenary program - no parallel sessions
Excellent opportunities for young investigators to present for the first time in their carreer in a comfortable and overseeable setting
Many of the world's leading phase 1 groups represented on TAT faculty
Related links:
Developed by Web4Bio